First Genetic Disease Identification Centre Launched In Kerala

Kerala Institute of Medical Sciences (KIMS) Hospital in collaboration with MedGenome has launched the first genetic disease identification center.

M. I. Sahadulla, chairman, KIMS Healthcare Group said their mission was to help patients and families with various genetic conditions through expert counseling and state of the art genetic testing facilities in complete confidentiality.

Potential Treatment for Deadly Genetic Disease Identified
Research has suggested that MPS IIIB is a devastating and currently untreatable disease that causes progressive damage to the brain.

‘The genetic disease identification center will identify patients with the risk of a genetic condition provide them information on genetic testing and treatment.’

Tweet it Now

This new collaboration envisages genetic counseling and testing for rare and common genetic, hereditary diseases that includes various types of cancers, cardiovascular, neurological and gastro-intestinal diseases, said Sahadulla.

In the first phase of the collaboration, the specialists at KIMS hospital will help identify patients at possible risk of a genetic condition and refer them to counselor who are specialized in gathering and analyzing family history and inheritance patterns of the disease.

They will provide information about genetic testing and related procedures for further investigations and treatment.

Additional Specialists, Improved Networking Among Doctors Key for India to Combat Rare Genetic Disease
Childcare experts in India have revealed that the country needs to improve its networking among doctors if it is to combat lysosomal storage disease (LSD).

In the second phase, statistical incidence, data collection and community based studies will be initiated.

"MedGenome will also partner with the clinicians in gaining underlying genetics insights into several human diseases and thereby address the pressing health problems of the common man," said Girish Mehta, CEO, MedGenome, India.

Researchers Question Effectiveness of Drug PTC124/Ataluren Used in Treating Genetic Diseases
Researchers have cast doubt on the mechanistic basis of a drug known as PTC124 (or Ataluren), used in treating genetic diseases.

Today congenital and hereditary genetic diseases are becoming a significant health burden in India, and hence there is a need for adequate and effective genetic testing and counseling services and in Kerala this new partnership is certainly going to help such patients.

Source-IANS

Undiagnosed Diseases Network to Study New and Rare Genetic Diseases
The National Institutes Of Health (NIH) has just begun a new program to help doctors working with rare diseases.